-----

Welcome to the March 2010 issue of Pharmaceutical Technology Sourcing and Management, your information resource about the pharmaceutical supply chain. In this issue, GE provides insight into the trends in upstream and downstream manufacturing of biologics. And in an exclusive podcast, Pfizer details its manufacturing strategy following its acquisition of Wyeth.

Biotech
The Opportunities, Challenges, and Trends in Biomanufacturing
A Q&A moderated by Patricia Van Arnum, senior editor, Pharmaceutical Technology and editor of Sourcing and Management
Nigel Darby, vice-president of biotechnologies at GE Healthcare Life Sciences and speaker at the Drug, Chemical, and Associated Technologies Association (DCAT) upcoming educational program on biologics, offers insight into the current and future state of upstream and downstream processing of biologics.
>> Read More

Manufacturing
Pfizer Outlines Manufacturing Strategy in Integrating Wyeth
Tony Maddaluna, senior vice-president of strategy and supply-network transformation at Pfizer Global Manufacturing, outlines the company’s manufacturing strategy in an exclusive podcast.
>> Read More

Contract manufacturing
Roundup of Informex 2010
Patricia Van Arnum, senior editor, Pharmaceutical Technology and editor of Sourcing and Management
At last month’s Informex, exhibitors announced expansions and new partnerships relating to contract manufacturing of active pharmaceuticals and intermediates and fine-chemicals supply.
>> Read More

Outsourcing
A Bio View of Outsourcing
Eric Langer, president of BioPlan Associates, and a periodic contributor to Pharmaceutical Technology’s Outsourcing Outlook
Strategic rather than tactical considerations are driving biopharmaceutical outsourcing.
>> Read More

-----

Pharma Views
When sourcing raw materials and non-GMP intermediates or other chemicals, where are your suppliers primarily located?
»Answer that question in Pharmaceutical Technology’s poll

-----

Sourcing and Management’s Community of Experts
The panel consists of leading professionals involved in the synthesis, manufacture, and sourcing of active pharmaceutical ingredients and intermediates, and experts in formulation and dosage-form manufacturing. The community of experts lends its expertise to the eNewsletter by providing reviews of technical articles as well as offering perspectives on topics of relevance to pharmaceutical manufacturers and their suppliers.
>> Read More

-----

INDUSTRY EVENTS

For the full listing of calendar of events, see the Calendar of Events page at:
http://pharmtech.findpharma.com/events

>>March 2010

Mar. 15-18
DCAT Week
New York

Mar. 30–31
BioFine Europe
Cambridge, UK

Apr. 20–22
Interphex
New York

May 3–6
BIO 2010
Chicago